ArticleJournal of experimental & clinical cancer research : CR2025

SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.

Xin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.